Please join us for an educational webinar hosted by Dr. Kristin Hillman, Clinical Pharmacist, Aegis Sciences Corporation.
In 2019, the COVID-19 pandemic collided with the opioid crisis significantly impacting people with Opioid Use Disorder. Dr. Hillman will discuss how temporary changes in telemedicine regulations increased patient access to treatment while reducing the risk of COVID-19 spread, and how these successes have led to additional changes to telemedicine regulations
Objectives Include:
- Review the history of telemedicine
- Discuss changes in telemedicine regulations for Opioid Treatment Programs (OTPs)
- Discuss how OTP clinicians have responded to telemedicine regulation changes
- Discuss the role of drug monitoring while utilizing telemedicine in OTPs
